| Total (n = 49) | RASi(+) (n = 37) | RASi(-) (n = 12) | p value |
---|---|---|---|---|
Age (y/o) | 47.2 ± 11.2 | 46.6 ± 11.8 | 49.3 ± 9.5 | 0.435 |
Male/female, n (male%) | 37/12 (75.5%) | 28/9 (75.7%) | 9/3 (75.0%) | 1.0 |
Systolic BP (mmHg) | 222 ± 28 | 220 ± 26 | 231 ± 32 | 0.364 |
Diastolic BP (mmHg) | 142 ± 21 | 144 ± 22 | 139 ± 18 | 0.323 |
Heart rate (beats/min) | 106 ± 19 | 109 ± 19 | 99 ± 17 | 0.081 |
BMI (kg/m2) | 29.5 ± 6.9 | 29.9 ± 7.4 | 28.4 ± 5.3 | 0.675 |
Previous hypertensive therapy, n (%) | ||||
 Aware of hypertension | 39 (79.6%) | 29 (78.4%) | 10 (83.3%) | 1.0 |
 Duration of hypertension | 7.6 ± 9.3 (y) | 5.7 ± 6.4 (y) | 13.2 ± 13.8 (y) | 0.127 |
  No treatment | 32 [82.1%] | 25 [86.2%] | 7 [70.0%] | 0.344 |
  Under treatment | 7 [17.9%] | 4 [13.8%] | 3 [30.0%] | |
   with RASi | 5 | 3 | 2 | 1.0 |
    CCBs | 6 | 3 | 3 | 1.0 |
    β blockers | 1 | 0 | 1 | 0.429 |
    Diuretics | 2 | 1 | 1 | 1.0 |
Diabetes, n (%) | 4 (8.2%) | 3 (8.1%) | 1 (8.3%) | 1.0 |
Smoking, n (%) | 26 (53.1%) | 21 (56.8%) | 5 (41.7%) | 0.508 |